Objective
Antibiotics remain valuable agents to fight infectious disease, but can also affect the normal gastrointestinal tract (GIT) microbiota resulting in detrimental symptoms. Despite the long therapeutic use of antibiotics, it is still unclear which components of the anaerobic gut microbiota are affected causing the development of antibiotic-associated diarrhoea (AAD), one of the most frequent side effects of antibiotic intake. It is also unknown whether the reduced number of commensal bacteria is sufficient to favour pathogen colonization, including by the most pathogenic agent linked to AAD, Clostridium difficile, or whether other conditions in the GIT change to promote pathogen colonization. The objectives of this proposal are (1) to rapidly monitor variations in the structure of the colonic microbial community thus identifying any population shifts due to tetracycline (Tc) therapy in human acne sufferers, (2) to investigate the effect of Tc treatment and other gut parameters on specific gene expression and the colonization ability of C. difficile isolates, and (3) to monitor changes in the occurrence and prevalence of specific tetracycline resistance (TcR) genes following long-term Tc treatment. The combination of the molecular ecology, molecular genetics and transcriptomic approaches that will be applied in this proposal will provide us with a deeper understanding of the role played by the GIT microbiota in human health, including how pathogens may gain control of the GIT ecosystem following antibiotic therapy, and finally of the contribution made by commensal GIT bacteria to the dissemination and emergence of bacterial antibiotic resistance.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciences biological sciences molecular biology molecular genetics
- natural sciences biological sciences microbiology bacteriology
- medical and health sciences health sciences infectious diseases
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs antibiotics
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance antibiotic resistance
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2007-2-1-IEF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
AB24 3FX Aberdeen
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.